PATENT CLAIM ANALYSIS

Application Number: 15775673
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2019-05
Patent Classification: ["435", "007320"]

Abstract:
The present invention discloses the use of  Mycobacterium tuberculosis  antigens for use in in vivodetermination of the presence of Mtbinfection in immunocompromised persons or persons co-infected with HIVand the for preparing a diagnostic reagent for skin testing (a skin test reagent) for robust assessment of the presence of Mtbinfection in an individual wherein the individual is an immunocompromised person or a person co-infected with HIV.

Claim (Index 18):
The method according to  claim 10 , wherein each antigen is present in an amount of 0.25-2.0 \u03bcg/mL.

Metadata:
- Claim Count in Document: 53.0
- Percentile: 93.0
- Lexical Diversity: 1.74359
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['10593384', '13263442', '11222449', '13811906', '15793746']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.5689710396343534
- 35 USC 102 Novelty (BERT): 0.5109522051450015
- Combined Prediction Score: 0.5631691561854182
- Mean Citation Score: 205.843506
- Max Citation Score: 210.93764
- Similarity Product: 124.75332888304708

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test